A multifunctional M1-like cell vehicle to intravesically deliver ICG for photodynamic therapy of bladder cancer

Intravesical drug delivery systems often fail to satisfy the requirement of multifunctionality in one entity, including mucoadhesion, tumor-selective binding and deep tumor-penetration. In this work, we engineered the surface of M1-like macrophages with both tumor-targeted and mucoadhesive ligands (R11) to develop a multifunctional cell vehicle (M1<sup>R11</sup>) for intravesical delivery of ICG. Remarkably, M1<sup>R11</sup> corrected the lysosomal trafficking of ICG, directed it to enter the transcellular pathway and thereby enhance its intra-tumoral penetration. When intravesically applied, the M1<sup>R11</sup>-delivered ICG displayed much improved photodynamic efficacy, ultimately eradicating orthotopic bladder tumors in most cases and achieving complete pathological response.

Authors

Institutions

Publication Details

Journal
Journal of Controlled Release
Published
2025-11-20
DOI
https://doi.org/10.1016/j.jconrel.2025.114428
Primary Topic
Bladder and Urothelial Cancer Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A multifunctional M1-like cell vehicle to intravesically deliver ICG for photodynamic therapy of bladder cancer

Chenkai Wang, Zhenghong Liu, Wentao Xu, Xiaowen Qin et al.
Journal of Controlled Release
Bladder and Urothelial Cancer Treatments
article

A multifunctional M1-like cell vehicle to intravesically deliver ICG for photodynamic therapy of bladder cancer

Chenkai Wang, Zhenghong Liu, Wentao Xu, Xiaowen Qin, Yang Liu, Qi Zhang, Pu Zhang, Heng Wang, Bin Zheng, Dahong Zhang, Wenbin Xue, Xuanyi Zhou, Li Sun, Yiyang Chen, Wei Zuo, Yixuan Mou, Dingyi Liu
article en

Abstract

Intravesical drug delivery systems often fail to satisfy the requirement of multifunctionality in one entity, including mucoadhesion, tumor-selective binding and deep tumor-penetration. In this work, we engineered the surface of M1-like macrophages with both tumor-targeted and mucoadhesive ligands (R11) to develop a multifunctional cell vehicle (M1<sup>R11</sup>) for intravesical delivery of ICG. Remarkably, M1<sup>R11</sup> corrected the lysosomal trafficking of ICG, directed it to enter the transcellular pathway and thereby enhance its intra-tumoral penetration. When intravesically applied, the M1<sup>R11</sup>-delivered ICG displayed much improved photodynamic efficacy, ultimately eradicating orthotopic bladder tumors in most cases and achieving complete pathological response.

Journal of Controlled ReleaseVol. 389
Harbin Medical University (CN), Hangzhou Medical College (CN)
Openalex Percentile: Top 46%
Bladder and Urothelial Cancer Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.